Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...
Each year, about 125 million opioid prescriptions are written for Americans with pain caused by broken bones, burns, ...
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...
The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive ...
CNBC’s Angelica Peebles and Vertex JournavxPharmaceuticals CEO Reshma Kewalramani join 'Squawk on the Street' to discuss the ...
An estimated 2.5 million American adults have an addiction to opioids, which were responsible for more than 107,000 fatal overdoses in 2023. Next in the study, published in the journal Drug ...
The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...